(Q37230910)

19 August 2017

1 reference

title

Pathogenesis and progression of monoclonal gammopathy of undetermined significance (English)

1 reference

19 August 2017

0 references

J Bladé

1

1 reference

19 August 2017

L Rosiñol

series ordinal

2

1 reference

19 August 2017

M T Cibeira

series ordinal

3

1 reference

19 August 2017

C F de Larrea

series ordinal

4

1 reference

19 August 2017

31 July 2008

1 reference

19 August 2017

1 reference

19 August 2017

22

1 reference

19 August 2017

9

1 reference

19 August 2017

1651-1657

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.203

19 August 2017

0 references

cites work

Clinical practice. Monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Monoclonal gammopathies in the adult population of Finistère, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Prevalence of monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Multiple myeloma and family history of cancer. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Genetic events in the pathogenesis of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

21 January 2018

Scleromyxedema revisited

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Smoldering multiple myeloma: natural history and recognition of an evolving type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

Monoclonal gammopathy of undetermined significance. Natural history in 241 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

A 20-year follow-up study of 64 subjects with M-components

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Occurrence of monoclonal components in general practice: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.203

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.203

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference